AU7578091A - Treatment of cachexia with interleukin 2 - Google Patents

Treatment of cachexia with interleukin 2

Info

Publication number
AU7578091A
AU7578091A AU75780/91A AU7578091A AU7578091A AU 7578091 A AU7578091 A AU 7578091A AU 75780/91 A AU75780/91 A AU 75780/91A AU 7578091 A AU7578091 A AU 7578091A AU 7578091 A AU7578091 A AU 7578091A
Authority
AU
Australia
Prior art keywords
cachexia
interleukin
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75780/91A
Inventor
David B Gough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU7578091A publication Critical patent/AU7578091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU75780/91A 1990-03-19 1991-03-19 Treatment of cachexia with interleukin 2 Abandoned AU7578091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49504990A 1990-03-19 1990-03-19
US495049 1990-03-19

Publications (1)

Publication Number Publication Date
AU7578091A true AU7578091A (en) 1991-10-21

Family

ID=23967049

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75780/91A Abandoned AU7578091A (en) 1990-03-19 1991-03-19 Treatment of cachexia with interleukin 2

Country Status (2)

Country Link
AU (1) AU7578091A (en)
WO (1) WO1991014444A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
EP3766513A1 (en) 2011-03-11 2021-01-20 Assistance Publique Hôpitaux de Paris Use of low dosage il-2 for treating vasculitis
BR112013023151A2 (en) 2011-03-11 2020-09-15 Assistance Publique - Hôpitaux De Paris interleukin-2 for use in the treatment of autoimmune, immune-related or inflammatory disorder and method for determining whether a regimen or dose of il-2 needs to be modified

Also Published As

Publication number Publication date
WO1991014444A1 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
AU639192B2 (en) Treatment of water
AU2377592A (en) Biomedical electrode
AU5433494A (en) Injector and use of the same
AU5727290A (en) Surface treatment of carbon microfibers
AU1608188A (en) Improved superabsorbent composition and process
AU8044491A (en) Antitumor compositions and methods of treatment
AU7484791A (en) Method of treating diseases associated with elevated levels of interleukin 1
AU1279788A (en) Compounds and treatment
AU8192691A (en) Method of treatment and compositions therefore
AU8427091A (en) Gamma-carboxylase and methods of use
AU3553489A (en) Novel compounds and treatment
AU4133693A (en) Surface treatment of refractories
GB9201920D0 (en) Novel treatment i
GB9007730D0 (en) Therapeutic compound and composition
IL104755A0 (en) Treatment of glaucoma
AU7578091A (en) Treatment of cachexia with interleukin 2
AU5371694A (en) Use of the tarchonanthus camphoratus
AU8185491A (en) Treatment of disease
AU9156391A (en) Moldable composition of matter
AU1593792A (en) Treatment of mastitis
AU8819691A (en) Treatment of gas
AU1604692A (en) Treatment of longitudinally extending members
AU4603289A (en) Novel treatment
AU3945393A (en) Treatment of hepatitis with GM-CSF
AU8110191A (en) Novel spergualin-related compound and use thereof